TY - JOUR
T1 - Measurement of physical activity in cancer survivors
T2 - A validity study
AU - Su, Ching Ching
AU - Lee, Kuan Der
AU - Yeh, Chung Hung
AU - Kao, Ching Chiu
AU - Lin, Chia Chin
N1 - Funding Information:
Acknowledgments This study was supported by the Taipei Medical University-Wan Fang Hospital (97TMU-WFH-05). The authors would like to thank all participants in this study.
PY - 2014/6
Y1 - 2014/6
N2 - Purpose: The purpose of the study was to validate the Taiwanese version of the Physical Activity Scale for the Elderly (PASE-T) and to assess physical activity in Taiwanese cancer survivors. Methods: One hundred twenty-seven cancer survivors participated in this study. Instruments consisted of the PASE-T, the Taiwanese version of the MD Anderson Symptom Inventory (MDASI-T), Karnofsky performance status (KPS), and actigraph. Reliability was assessed by calculating the test-retest reliability. The validity was assessed by the content validity, criterion-related validity, convergent validity, and known-group validity. Results: The test-retest reliability of PASE-T was 0.90 over a 2-week interval, based on a sample of 30 patients. The content validity index was very acceptable at 0.91. Convergent validity was demonstrated by its significant association with MDASI-T scores (symptom severity: r = -0.23, p = 0.001; symptom interference: r = -0.21, p = 0.001) and KPS scores (r = 0.59, p <0.001). Criterion-related validity was established by a significant relationship to the actigraph total counts per minute (r = 0.64, p <0.001). Known-group validity was established by its ability to detect significant differences according to a patient's performance status. Moreover, KPS (β = 0.37), fatigue (β = -0.32), and age (β = -0.20) were significant predictors of physical activity (R 2 = 0.46). Conclusions: The PASE-T is a reliable and valid instrument for measurement of physical activity among cancer survivors in Taiwan. Implication for Cancer Survivors: This scale could be a useful measure of physical activity in cancer survivors and subsequently facilitate the quality of oncology care.
AB - Purpose: The purpose of the study was to validate the Taiwanese version of the Physical Activity Scale for the Elderly (PASE-T) and to assess physical activity in Taiwanese cancer survivors. Methods: One hundred twenty-seven cancer survivors participated in this study. Instruments consisted of the PASE-T, the Taiwanese version of the MD Anderson Symptom Inventory (MDASI-T), Karnofsky performance status (KPS), and actigraph. Reliability was assessed by calculating the test-retest reliability. The validity was assessed by the content validity, criterion-related validity, convergent validity, and known-group validity. Results: The test-retest reliability of PASE-T was 0.90 over a 2-week interval, based on a sample of 30 patients. The content validity index was very acceptable at 0.91. Convergent validity was demonstrated by its significant association with MDASI-T scores (symptom severity: r = -0.23, p = 0.001; symptom interference: r = -0.21, p = 0.001) and KPS scores (r = 0.59, p <0.001). Criterion-related validity was established by a significant relationship to the actigraph total counts per minute (r = 0.64, p <0.001). Known-group validity was established by its ability to detect significant differences according to a patient's performance status. Moreover, KPS (β = 0.37), fatigue (β = -0.32), and age (β = -0.20) were significant predictors of physical activity (R 2 = 0.46). Conclusions: The PASE-T is a reliable and valid instrument for measurement of physical activity among cancer survivors in Taiwan. Implication for Cancer Survivors: This scale could be a useful measure of physical activity in cancer survivors and subsequently facilitate the quality of oncology care.
KW - Cancer survivors
KW - Physical activity
KW - Reliability
KW - Validation
KW - Validity
UR - http://www.scopus.com/inward/record.url?scp=84900325457&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84900325457&partnerID=8YFLogxK
U2 - 10.1007/s11764-013-0325-3
DO - 10.1007/s11764-013-0325-3
M3 - Article
C2 - 24317970
AN - SCOPUS:84900325457
SN - 1932-2259
VL - 8
SP - 205
EP - 212
JO - Journal of Cancer Survivorship
JF - Journal of Cancer Survivorship
IS - 2
ER -